ArrowMark Colorado Holdings’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $509K | Hold |
25,000
| – | – | 0.01% | 273 |
|
|
2025
Q1 | $454K | Hold |
25,000
| – | – | 0.01% | 274 |
|
|
2024
Q4 | $632K | Hold |
25,000
| – | – | 0.01% | 274 |
|
|
2024
Q3 | $850K | Hold |
25,000
| – | – | 0.01% | 255 |
|
|
2024
Q2 | $925K | Hold |
25,000
| – | – | 0.01% | 267 |
|
|
2024
Q1 | $1.05M | Buy |
+25,000
| New | +$1.05M | 0.01% | 265 |
|
|
2013
Q4 | – | Sell |
-3,635
| Closed | -$1.93M | – | 277 |
|
|
2013
Q3 | $1.93M | Buy |
3,635
+615
| +20% | +$327K | 0.06% | 179 |
|
|
2013
Q2 | $707K | Buy |
+3,020
| New | +$707K | 0.19% | 68 |
|